Skip to main content
. 2019 Oct 30;2019(10):CD004659. doi: 10.1002/14651858.CD004659.pub3

Spain 2017.

Methods Randomised
Participants 186 women aged 18 years or older with a singleton pregnancy, crown rump length 45 mm to 84 mm, an abnormal Doppler at 11 to 14 weeks and no other risk factors for PE
Interventions Aspirin 150 mg extended release vs placebo, until 28 weeks' gestation
Outcomes Pulsatility index at 28 weeks; PE; early onset PE (delivery before 34 weeks); severe PE; SGA, neonatal metabolic acidosis at birth.
Notes Conducted at three university hospitals in Spain.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Web‐based randomisation, stratified by site
Allocation concealment (selection bias) Low risk Sites contacted a central office for randomisation, which then sent them the allocation by fax.
Blinding (performance bias and detection bias) 
 All outcomes Low risk Women, caregivers and investigator described as blind to the allocation.
Incomplete outcome data (attrition bias) 
 All outcomes High risk 31/186 (17%) women excluded from analysis: lost to follow‐up (7 aspirin vs 6 placebo)' voluntary withdrawal (6 vs 5), preterm birth < 28 weeks 1 vs 1), congenital malformation (1 vs 1), miscarriage, (2 vs 0), asthma attack 0 vs 1).
Selective reporting (reporting bias) Unclear risk Protocol not available. Outcome reported for those listed in methods, with some additional outcome data reported that are not in methods.
Other bias Low risk Baseline characteristics balanced between groups (see table 1).